University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection

Phase 1

Completed

Conditions: HIV Infection

Interventions: Biological: PLACEBO
Biological: PENNVAX-B
Biological: GENEVAX IL-12-4532
Biological: IL-15 adjuvant

First Posted Date: 2008-10-20

Last Posted Date: 2016-08-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 38

Registration Number: NCT00775424

Locations: 🇺🇸
University of Pennsylvania. Clinical Trials Unit, Philadelphia, Pennsylvania, United States

Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.

Phase 2

Completed

Conditions: Traumatic Brain Injury

Interventions: Drug: Placebo
Drug: Recombinant human Growth Hormone

First Posted Date: 2008-10-03

Last Posted Date: 2019-11-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 63

Registration Number: NCT00766038

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Center for NeuroSkills, Bakersfield, California, United States
🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

Depot Naltrexone Treatment of Opioid Dependent Parolees

Not Applicable

Completed

Conditions: Opioid Dependence

Interventions: Drug: Depot Naltrexone

First Posted Date: 2008-09-22

Last Posted Date: 2019-04-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 61

Registration Number: NCT00756990

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Testing Strategies for Weight Loss, II

Phase 1

Completed

Conditions: Obesity

Interventions: Behavioral: financial incentives

First Posted Date: 2008-08-21

Last Posted Date: 2016-12-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 66

Registration Number: NCT00739492

Locations: 🇺🇸
Philadelphia Veterans Administration Medical Center, Philadelphia, Pennsylvania, United States

Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study

Phase 2

Completed

Conditions: Dyslipidemia

Interventions: Drug: Atorvastatin
Drug: ABT335
Drug: ER Niacin

First Posted Date: 2008-08-06

Last Posted Date: 2016-02-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 25

Registration Number: NCT00728910

Locations: 🇺🇸
CTRC (Clinical Translational Research Center), Philadelphia, Pennsylvania, United States

Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters

Not Applicable

Completed

Conditions: Venous Thrombosis

Interventions: Device: Tapered PICC
Device: Non-tapered PICC

First Posted Date: 2008-08-06

Last Posted Date: 2018-04-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 339

Registration Number: NCT00728819

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Dietary Intake and Eating Behaviors in Adolescents Who Undergo Bariatric Surgery

Completed

Conditions: Eating Behavior
Adolescent Obesity
Dietary Intake

First Posted Date: 2008-07-24

Last Posted Date: 2016-08-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 160

Registration Number: NCT00721838

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

and more 2 locations

Varenicline (Chantix™) for the Treatment of Alcohol Dependence

Phase 2

Completed

Conditions: Alcoholism

Interventions: Drug: placebo
Drug: varenicline

First Posted Date: 2008-06-26

Last Posted Date: 2015-06-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 40

Registration Number: NCT00705523

Locations: 🇺🇸
University of Pennsylvania Treatment Research Center, Philadelphia, Pennsylvania, United States

Effectiveness of Extended Treatments for Drug Dependence

Not Applicable

Completed

Conditions: Cocaine Dependence

Interventions: Other: Intensive Outpatient Treatment
Other: Adaptive telephone-based counseling
Other: Adaptive telephone-based counseling plus incentives

First Posted Date: 2008-05-28

Last Posted Date: 2017-08-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 332

Registration Number: NCT00685659

Locations: 🇺🇸
NorthEast Treatment Centers, Philadelphia, Pennsylvania, United States
🇺🇸
Presbyterian Hospital, Philadelphia, Pennsylvania, United States

Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma

Phase 1

Completed

Conditions: Melanoma

Interventions: Drug: cyclophosphamide
Biological: Mature dendritic cell vaccine

First Posted Date: 2008-05-23

Last Posted Date: 2017-02-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 17

Registration Number: NCT00683670

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy